Factors determining post-operative readmissions after left ventricular assist device implantation.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  G. Stevens,et al.  Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. , 2013, The Annals of thoracic surgery.

[3]  C. Gross,et al.  Use of hospital-based acute care among patients recently discharged from the hospital. , 2013, JAMA.

[4]  Yariv N. Marmor,et al.  Readmissions after implantation of axial flow left ventricular assist device. , 2013, Journal of the American College of Cardiology.

[5]  Patrick S. Romano,et al.  Hospital Variation in Readmission After Coronary Artery Bypass Surgery in California , 2012, Circulation. Cardiovascular quality and outcomes.

[6]  Samin K. Sharma,et al.  30-day readmission for patients undergoing percutaneous coronary interventions in New York state. , 2011, JACC. Cardiovascular interventions.

[7]  E. Hannan,et al.  30-day readmissions after coronary artery bypass graft surgery in New York State. , 2011, JACC. Cardiovascular interventions.

[8]  J. Rogers,et al.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. , 2010, The Annals of thoracic surgery.

[9]  Nir Uriel,et al.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  J. Stone.  Medicare Hospital Readmissions: Issues, Policy Options and PPACA , 2010 .

[11]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[12]  H. Luft,et al.  Medicare's policy not to pay for treating hospital-acquired conditions: the impact. , 2009, Health affairs.

[13]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[14]  P. Royle,et al.  Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: A systematic review and economic evaluation , 2007, International Journal of Technology Assessment in Health Care.

[15]  B. Friedman,et al.  The Rate and Cost of Hospital Readmissions for Preventable Conditions , 2004, Medical care research and review : MCRR.

[16]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.